Cargando…

Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma

Immunotherapy is increasingly used in the treatment of glioblastoma (GBM), with immune checkpoint therapy gaining in popularity given favorable outcomes achieved for other tumors. However, immune-mediated (IM)-pseudoprogression is common, remains poorly characterized, and renders conventional imagin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daghighi, Shadi, Bahrami, Naeim, Tom, William J., Coley, Nicholas, Seibert, Tyler M., Hattangadi-Gluth, Jona A., Piccioni, David E., Dale, Anders M., Farid, Nikdokht, McDonald, Carrie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997150/ https://www.ncbi.nlm.nih.gov/pubmed/32047723 http://dx.doi.org/10.3389/fonc.2020.00024

Ejemplares similares

The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis
por: Salans, Mia, et al.
Publicado: (2023)

Analyses of regional radiosensitivity of white matter structures along tract axes using novel white matter segmentation and diffusion imaging biomarkers
por: Houri, Jordan, et al.
Publicado: (2018)

LMAP-17 FEASIBILITY OF COGNITIVE-SPARING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES: INITIAL REPORT OF PHASE II COG-SRS TRIAL
por: Hopper, Austin, et al.
Publicado: (2023)

Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
por: Wang, Wesley, et al.
Publicado: (2023)

Automated segmentation of multiparametric magnetic resonance images for cerebral AVM radiosurgery planning: a deep learning approach
por: Simon, Aaron B., et al.
Publicado: (2022)

Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation
por: Qian, Xiaohua, et al.
Publicado: (2016)

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma
por: Verma, Gaurav, et al.
Publicado: (2018)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

NEIM-02 DEVELOPMENT OF A DEEP LEARNING MODEL FOR DISCRIMINATING TRUE PROGRESSION FROM PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
por: Moassefi, Mana, et al.
Publicado: (2022)

Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM
por: Farid, Nikdokht, et al.
Publicado: (2013)

Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

Automatic patient positioning and gating window settings in respiratory‐gated stereotactic body radiation therapy for pancreatic cancer using fluoroscopic imaging
por: Pettersson, Niclas, et al.
Publicado: (2018)

A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression
por: Zhang, Peng, et al.
Publicado: (2015)

Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
por: Kinger, Nikhar, et al.
Publicado: (2019)

Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021)

True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis
por: Song, Yong Sub, et al.
Publicado: (2013)

High levels of cellular proliferation predict pseudoprogression in glioblastoma patients
por: POULEAU, HENRI-BENJAMIN, et al.
Publicado: (2011)

Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
por: Sidibe, Ingrid, et al.
Publicado: (2022)

Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients
por: McKenney, Anna Sophia, et al.
Publicado: (2022)

Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis
por: Taylor, Chris, et al.
Publicado: (2022)

Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
por: Brahm, Cyrillo G., et al.
Publicado: (2018)

Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
por: Linhares, Paulo, et al.
Publicado: (2013)

Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma
por: Jang, Bum-Sup, et al.
Publicado: (2018)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas
por: de Godoy, Laiz Laura, et al.
Publicado: (2023)

LMAP-20 EVIDENCE-BASED MULTIVARIATE NORMAL TISSUE COMPLICATION PROBABILITY (NTCP) STUDY OF DOMAIN-SPECIFIC COGNITIVE DECLINE AFTER PARTIAL BRAIN RT
por: Hopper, Austin, et al.
Publicado: (2023)

Assessing the added value of apparent diffusion coefficient, cerebral blood volume, and radiomic magnetic resonance features for differentiation of pseudoprogression versus true tumor progression in patients with glioblastoma
por: Leone, Riccardo, et al.
Publicado: (2023)

Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps
por: Reimer, Caroline, et al.
Publicado: (2017)

The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma
por: Xi, Jing, et al.
Publicado: (2021)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

True Ringworm
por: Hutchison, Jona.
Publicado: (1861)

Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial
por: Liu, Zhi-Cheng, et al.
Publicado: (2017)

Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted Images
por: Treiber, Jeffrey Mark, et al.
Publicado: (2016)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning
por: Lee, Joonsang, et al.
Publicado: (2020)

Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
por: Sun, Ying-Zhi, et al.
Publicado: (2021)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dumleuc0ntimll47qre5ps1gil